A forthcoming European conference aims to bring together deal- and decision-makers from the drug, biotechnology and medical device industries.
The second annual BioDevice Partnering conference will be held at Zurich’s Technopark on 12–13 June.
BioDevice aims to be a focal point for companies seeking to identify business opportunities and strike deals that drive future business. Last year’s inaugural BioDevice Partnering conference gathered 330 delegates from 214 companies representing 21 different countries from the biotech/pharmaceutical, medical technology, financial, legal and consulting communities.
Highlights this year include opportunities and challenges for new medical technologies; the changing world of orthopaedics; biomaterials and polymers; and creative regulatory pathways to commercialisation.
The meeting is organised by life-sciences partnering firm EBD Group and European medical technology trade association Eucomed.